Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



POTTER MYRTLE S Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 4 POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.
Txns: Exercised 68 restricted stock units @ $0
07/17/2023 4 POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.
Txns: Exercised 69 restricted stock units @ $0
06/16/2023 4 POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.
Txns: Exercised 5,531 restricted stock units @ $0
Granted 8,803 options to buy @ $38.005, valued at $334.6k
Granted 5,592 restricted stock units @ $0
Exercised 68 restricted stock units @ $0
05/16/2023 4 POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.
Txns: Exercised 68 restricted stock units @ $0
04/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/16/2023 4 POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.
Txns: Granted 68 restricted stock units @ $0
Exercised 68 restricted stock units @ $0
03/10/2023 4 POTTER MYRTLE S (Director) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Disposed/sold 3,673 shares @ $0
Disposed/sold 45,000 options to buy @ $26.17, valued at $1.2M
Disposed/sold 58,608 options to buy @ $7.65, valued at $448.4k
Disposed/sold 21,603 options to buy @ $21.47, valued at $463.8k
Disposed/sold 21,096 options to buy @ $22.71, valued at $479.1k
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/18/2022 4 POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.
Txns: Exercised 820 restricted stock units @ $0
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/10/2021 4 POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.
Txns: Granted 3,283 restricted stock units @ $0
Granted 5,613 options to buy @ $110.43, valued at $619.8k
11/09/2021 4 POTTER MYRTLE S (Director) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Granted 21,096 options to buy @ $22.71, valued at $479.1k
10/27/2021 3 POTTER MYRTLE S (Director) has filed a Form 3 on Guardant Health, Inc.
03/31/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/17/2020 4 POTTER MYRTLE S (Director) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Granted 21,603 options to buy @ $21.47, valued at $463.8k
07/23/2020 4 POTTER MYRTLE S (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 9,000 shares @ $0
Granted 15,000 options to buy @ $9.38, valued at $140.7k
01/14/2020 4 POTTER MYRTLE S (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 12,480 shares @ $0
12/20/2019 4 POTTER MYRTLE S (Director) has filed a Form 4 on Immunovant, Inc.
Txns: Granted 137,617 options to buy @ $7.86, valued at $1.1M
Granted 893 options to buy @ $7.86, valued at $7k
Granted 11,488 options to buy @ $8.43, valued at $96.8k
Granted 3,765 options to buy @ $8.43, valued at $31.7k
12/20/2019 3 POTTER MYRTLE S (Director) has filed a Form 3 on Immunovant, Inc.
08/27/2019 4 POTTER MYRTLE S (Director) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Granted 58,608 options to buy @ $7.65, valued at $448.4k
08/20/2019 4 POTTER MYRTLE S (Director) has filed a Form 4 on Arbutus Biopharma Corp
Txns: Granted 22,000 options @ $0
07/11/2019 4 POTTER MYRTLE S (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 25,000 options to buy @ $8.78, valued at $219.5k
06/10/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/17/2019 4 POTTER MYRTLE S (Director) has filed a Form 4 on Axovant Sciences Ltd.
Txns: Granted 255,000 options to buy @ $1.06, valued at $270.3k
11/26/2018 4 POTTER MYRTLE S (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 50,000 options to buy @ $8.01, valued at $400.5k
10/22/2018 4 POTTER MYRTLE S (Director) has filed a Form 4 on Arbutus Biopharma Corp
Txns: Granted 44,000 options to buy @ $4.71, valued at $207.2k
10/22/2018 3 POTTER MYRTLE S (Director) has filed a Form 3 on Arbutus Biopharma Corp
10/16/2018 4 POTTER MYRTLE S (Director) has filed a Form 4 on Axovant Sciences Ltd.
Txns: Granted 150,000 options to buy @ $2.37, valued at $355.5k
10/05/2018 3 POTTER MYRTLE S (Director) has filed a Form 3 on Axovant Sciences Ltd.
09/26/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
09/24/2018 4 POTTER MYRTLE S (Director) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Granted 45,000 options to buy @ $26.17, valued at $1.2M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy